Skip to main content
. 2020 Aug 27;41(1):72–135. doi: 10.1002/med.21724

Figure 38.

Figure 38

Nucleoside analogs with inhibition activity against SARS‐CoV‐2 RdRP (adenosine, guanosine, and sofosbuvir are included for comparison). RdRP, RNA‐dependent RNA polymerase; SARS‐CoV, severe acute respiratory syndrome coronavirus